KUNZ THERAPEUTICS LTD

Registered Number: 11172563

England and Wales

Unaudited Financial Statements

for the year ended 31 January 2025

for

KUNZ THERAPEUTICS LTD

KUNZ THERAPEUTICS LTD

Statement of Financial Position

As at 31 January 2025

	£	2025 £	£	2024 £
Fixed assets		5,909		2,388
Current assets	126,092		94,344
Creditors: amount falling due within one year	(41,053)		(16,941)
Net current assets/(liabilities)		85,039		77,403
Total assets less current liabilities		90,948		79,791
Net assets/(liabilities)		90,948		79,791


Capital and reserves		90,948		79,791

For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:

----------------------------------
Parvathi Nallamchetty
Director

Date approved: 31 October 2025

KUNZ THERAPEUTICS LTD

Notes to the Accounts

For the year ended 31 January 2025

Statutory Information

KUNZ THERAPEUTICS LTD is a private limited company, limited by shares, domiciled in England and Wales, registration number 11172563, registered office 31 Sandiacre, West Timperley, Altrincham, WA14 5HN, United Kingdom.

The presentation currency is £ sterling.

1.	Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

2.	Average number of employees Average number of employees during the year were 2 (2024: 2).

3.	Director Advances Credits Note As at 31 January 2025 The Director, Parvathi Nallamchetty, owed Kunz Therapeutics Limited £0 (31 January 2024 £5,102)